Recent Advances in Drug Delivery Approaches for Rheumatoid Arthritis

Title:Recent Advances in Drug Delivery Approaches for Rheumatoid Arthritis

Volume: 31

Author(s): Abhishek Verma, Preeti Patel, Waleed Hassan Almalki, Amirhossein Sahebkar*, Balak Das Kurmi*Prashant Kesharwani*

Affiliation:

• Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
• Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

• Department of Pharmaceutics, ISF College of Pharmacy, GT Road, Moga, 142001, Punjab, India

• Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, 110062, India
• Center for Transdisciplinary Research, Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Science, Chennai, India
• University Institute of Pharma Sciences, Chandigarh University, Mohali, Punjab, India

Abstract: Morbidity, disability, and healthcare expenses associated with rheumatoid arthritis (RA) impose a considerable health and economical burden on both patients and healthcare systems. This review aimed to examine the pathophysiological aspects of RA that may help design different types of drugs and drug delivery systems. These include monoclonal antibodies, immunoglobulins, tiny chemicals, and transgenes for gene therapy. These novel nanocarrier-based therapies target the underlying biological processes involved in RA while minimizing the systemic adverse effects of drugs.

Cite this article as:

Verma Abhishek, Patel Preeti, Almalki Hassan Waleed, Sahebkar Amirhossein*, Kurmi Das Balak*, Kesharwani Prashant*, Recent Advances in Drug Delivery Approaches for Rheumatoid Arthritis, Current Medicinal Chemistry 2024; 31 () . https://dx.doi.org/10.2174/0929867331666230815112818